KLINGENSTEIN FIELDS & CO LP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 97 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.

Quarter-by-quarter ownership
KLINGENSTEIN FIELDS & CO LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$51,000
+4.1%
10,6180.0%0.00%0.0%
Q2 2021$49,000
-21.0%
10,6180.0%0.00%
-33.3%
Q1 2021$62,000
+72.2%
10,6180.0%0.00%
+50.0%
Q4 2020$36,000
+140.0%
10,6180.0%0.00%
+100.0%
Q3 2020$15,000
-28.6%
10,6180.0%0.00%0.0%
Q2 2020$21,0000.0%10,6180.0%0.00%0.0%
Q1 2020$21,000
-52.3%
10,6180.0%0.00%
-50.0%
Q4 2019$44,000
+37.5%
10,6180.0%0.00%0.0%
Q3 2019$32,000
-52.2%
10,6180.0%0.00%
-33.3%
Q2 2019$67,000
+13.6%
10,6180.0%0.00%0.0%
Q1 2019$59,000
-16.9%
10,6180.0%0.00%0.0%
Q4 2018$71,000
-37.2%
10,6180.0%0.00%
-25.0%
Q3 2018$113,000
-11.0%
10,6180.0%0.00%
-20.0%
Q2 2018$127,000
+39.6%
10,6180.0%0.01%
+66.7%
Q1 2018$91,000
-13.3%
10,6180.0%0.00%
-25.0%
Q4 2017$105,000
-37.1%
10,618
-22.0%
0.00%
-33.3%
Q3 2017$167,000
-25.4%
13,6180.0%0.01%
-33.3%
Q2 2017$224,000
+4.7%
13,618
-8.6%
0.01%0.0%
Q1 2017$214,000
+3.9%
14,9030.0%0.01%0.0%
Q4 2016$206,000
-23.4%
14,9030.0%0.01%
-25.0%
Q3 2016$269,000
+25.7%
14,9030.0%0.01%
+20.0%
Q2 2016$214,000
+20.2%
14,9030.0%0.01%
+11.1%
Q1 2016$178,000
-10.1%
14,9030.0%0.01%
-10.0%
Q4 2015$198,000
+23.8%
14,9030.0%0.01%
+25.0%
Q3 2015$160,00014,9030.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders